SENNA PLUS

Manufacturer
DIRECTRX
Effective date
2019-03-05
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 00:29:56

Label at a glance#

ProductSENNA PLUS
Active ingredientSENNOSIDES, DOCUSATE SODIUM
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION


Docusate Sodium 50 mg
Sennosides 8.6 mg

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)

generally produces bowel movement in 6 to 12 hours

OTC - PURPOSE SECTION


Docusate Sodium 50 mg
Sennosides 8.6 mg

WARNINGS SECTION

Do not use for more than 1 week unless directed by a doctor

Ask a doctor before use if you -have abdominal pain, nausea or vomiting -are taking mineral oil -have noticed a sudden change in bowel habits that lasts over 2 weeks

Stop use and ask a doctor if -you have no bowel movement within 12 hours -you have rectal bleeding. these could signs of a serious condition.

if pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

INSTRUCTIONS FOR USE SECTION

do not exceed 8 tablets in 24 hours

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor
4 tablets in the morning and 4 tablets at bedtime
children under 12 years
ask a doctor

OTC - ACTIVE INGREDIENT SECTION

each tablet contains: calcium 7 mg

• store at room temperature

INACTIVE INGREDIENT SECTION


cellulose, croscarmellose sodium, dicalcium phosphate, FD and C yellow no. 5 (tartrazine), FD and C yellow no. 6, hypromellose, magnesium silicate, magnesium stearate, mineral oil, PEG, sodium benzoate, sodium lauryl sulfate, starch, stearic acid, titanium dioxide, triacetin

DOSAGE & ADMINISTRATION SECTION

o not exceed 8 tablets in 24 hours

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor
4 tablets in the morning and 4 tablets at bedtime
children under 12 years
ask a doctor

OTC - KEEP OUT OF REACH OF CHILDREN SECTION


Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

684-60684-60

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
57896-455-01EA - Each57896-4550f219bae-0f6b-42bf-b51b-1eabc0b9b74812013-05-02
57896-455-06EA - Each57896-455998bed0f-dc2d-4ae5-8192-7e025d26cbc812015-07-20
57896-455-10EA - Each57896-4559eb9f425-a2c3-4683-bc38-aa178b0407f312018-04-19

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
61919-68461919-684-60
57896-455

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
071193ac-34dc-244b-e063-6294a90a9e7c830d195a-d5d5-b3e5-e053-2991aa0aee2a2023-10-06WarningsExact identifier
spl set id: 830d195a-d5d5-b3e5-e053-2991aa0aee2a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.